This study tests a new treatment for women whose ovarian cancer has come back. It combines chemotherapy and immunotherapy given directly into the abdomen with a drug given through a vein. The goal is to see if this approach can shrink or eliminate tumors. The study involves 24 pa…
Phase: PHASE1, PHASE2 • Sponsor: Robert Edwards • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC